160 Health International Limited
Research 160 Health International Limited (2656.HK) on Bullrun: market cap HKD 864.63M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2656.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyHKD
- Market capHKD 864.63M
- Financial periodQ2 2025
- RevenueCNY 190.19M
- Net income-CNY 3.62M
- Free cash flowCNY 7.42M
- Gross margin19.0%
Valuation Snapshot
latest market cap is HKD 864.63M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 864.63M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About 160 Health International Limited
160 Health International Limited wholesales and retails pharmaceutical and healthcare products in China. Thedevelops Healthcare 160 Platform, an online healthcare and wellness service platform which provides digital healthcare and wellness solutions, including online marketing solutions, digital hospital solutions, and online healthcare services to business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is 160 Health International Limited's market cap?
160 Health International Limited's market capitalization is HKD 864.63M.
What does 160 Health International Limited do?
160 Health International Limited wholesales and retails pharmaceutical and healthcare products in China. Thedevelops Healthcare 160 Platform, an online healthcare and wellness service platform which provides digital healthcare and wellness solutions, including online marketing solutions, digital hospital solutions, and online healthcare services to business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants. 160 Health International Limited was founded in 2005 and is headquartered in Shenzhen, the People's Republic of China.